Latest Stories
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.
FAST Q1 Earnings Call: Management Addresses Tariffs, Supply Chain, and Digital Strategy
Industrial supplier Fastenal (NASDAQ:FAST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.96 billion. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.
UAL Q1 Earnings Call: Brand Loyalty and Capacity Adjustments Drive Outperformance in Uncertain Market
Airline company United Airlines Holdings (NASDAQ:UAL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $13.21 billion. Its non-GAAP profit of $0.91 per share was 23.8% above analysts’ consensus estimates.